The clinical study about levetiracetam on cognitive function and emotional influence in the patients with partial epilepsy
10.3760/cma.j.issn.1673-4904.2014.28.018
- VernacularTitle:左乙拉西坦对部分性癫痫患者认知功能及情绪影响的研究
- Author:
Jianlei ZHANG
;
Guofei LI
;
Na CHANG
;
Zhaohui WANG
;
Dajian LIU
;
Weiya HE
- Publication Type:Journal Article
- Keywords:
Levetiracetam;
Carbamazepine;
Epilepsy;
Cognitive function;
Emotions
- From:
Chinese Journal of Postgraduates of Medicine
2014;37(28):55-57
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical influence about levetiracetam on cognitive function and emotional influence in the patients with partial epilepsy.Methods A total of 62 patients with partial epilepsy were divided into carbamazepine group (30 cases) and levetiracetam group (32 cases) by random digits table method,carbamazepine group was treated by carbamazepine while levetiracetam group was treated by levetiracetam.The patients were assessed before treatment and 4,8,12,16 weeks after treatment by the Montreal cognitive assessment scale (MoCA),self rating anxiety scale (SAS) and self rating depression scale (SDS).Results There was no significant difference in MoCA score between two groups before treatment and 4 weeks after treatment (P ＞ 0.05).MoCA score at 8,12,16 weeks after treatment in levetiracetam group was better than that in carbamazepine group [(22.6 ± 2.1) scores vs.(20.8 ± 2.6) scores,(23.5±2.7) scoresvs.(21.3± 2.8) scores,(24.6±4.7) scoresvs.(21.2±3.0) scores],the difference was statistically significant (P ＜ 0.05).There was no significant difference between SAS score,SDS score between two groups before and after treatment (P ＞ 0.05).Conclusion In the process of treating the patients with partial epilepsy by drug,levetiracetam is superior to carbamazepine on the improvement of cognitive function,but the mood improvement is not obvious.
